Estrella Immunopharma (ESLAW) Analyst & Key Data

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$0.07

DCF Value-64.42%

$0.02

Potential downside vs current price

Current Stock Price

$0.07

DCF Value-64.42%

$0.02

Potential downside vs current price

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$0.07

DCF Value-64.42%

$0.02

Potential downside vs current price

Current Stock Price

$0.07

DCF Value-64.42%

$0.02

Potential downside vs current price

Estrella Immunopharma, Inc.